ANI Pharmaceuticals, American Superconductor Touted as Top Growth Picks; Varonis Avoided, StockStory Says

StockStory on May 29, 2026, named ANI Pharmaceuticals (ANIP) and American Superconductor (AMSC) as growth stocks with strong upside potential, while advising investors to avoid Varonis Systems (VRNS), citing unsustainable trajectories. ANI Pharmaceuticals delivered one-year revenue growth of 37%, with shares trading at $81.10 and a forward price-to-sales ratio of 1.5. American Superconductor posted 34.3% revenue growth, priced at $51.04 per share with a 51.1 forward P/E multiple. Varonis Systems, which increased revenue 15.2% over the same period, traded at $31.33 and a 4.6 forward price-to-sales ratio, a valuation the research firm deemed unattractive. The recommendations follow a market that has rapidly separated quality stocks from overvalued names, analysts noted.